Showing results (171-180 of 198) with videos related to
Sort By:
Pageof 20
ACS Medicinal Chemistry Letters|February 21, 2015
Pure Diastereomers of a Tranylcypromine-Based LSD1 Inhibitor: Enzyme Selectivity and In-Cell StudiesSergio Valente, Veronica Rodriguez, Ciro Mercurio, et al.ACS Infectious Diseases|July 2, 2025
Tranylcypromine-Based LSD1 Inhibitors as Useful Agents to Reduce Viability of Schistosoma mansoniEmanuele Fabbrizi, Gebremedhin Solomon Hailu, A Ganesan, et al.European Journal of Medicinal Chemistry|September 1, 2014
Synthesis, biological activity and mechanistic insights of 1-substituted cyclopropylamine derivatives: a novel class of irreversible inhibitors of histone demethylase KDM1APaola Vianello, Oronza A Botrugno, Anna Cappa, et al.Science Advances|April 15, 2020
Targeting the scaffolding role of LSD1 (KDM1A) poises acute myeloid leukemia cells for retinoic acid-induced differentiationRoberto Ravasio, Elena Ceccacci, Luciano Nicosia, et al.Journal of Medicinal Chemistry|December 26, 2015
Discovery of a Novel Inhibitor of Histone Lysine-Specific Demethylase 1A (KDM1A/LSD1) as Orally Active Antitumor AgentPaola Vianello, Oronza A Botrugno, Anna Cappa, et al.ACS Chemical Biology|June 1, 2013
Protein recognition by short peptide reversible inhibitors of the chromatin-modifying LSD1/CoREST lysine demethylaseMarcello Tortorici, Maria Teresa Borrello, Maria Tardugno, et al.Iscience|July 20, 2022
Fine-tuned KDM1A alternative splicing regulates human cardiomyogenesis through an enzymatic-independent mechanismVeronica Astro, Gustavo Ramirez-Calderon, Roberta Pennucci, et al.European Journal of Medicinal Chemistry|March 14, 2015
Pure enantiomers of benzoylamino-tranylcypromine: LSD1 inhibition, gene modulation in human leukemia cells and effects on clonogenic potential of murine promyelocytic blastsSergio Valente, Veronica Rodriguez, Ciro Mercurio, et al.European Journal of Medicinal Chemistry|May 13, 2023
Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitorsMariagrazia Rullo, Gabriella La Spada, Daniela Valeria Miniero, et al.ACS Infectious Diseases|May 6, 2017
A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase InhibitorsMarta Esposito, Sára Szadocka, Giulia Degiacomi, et al.Pageof 20